Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Olaparib and BRCA2-Dependent DNA Gap Repair
2026-09-10
Olaparib (AZD2281) reveals how PARP inhibition reshapes nascent-strand maturation and BRCA2-dependent gap repair. This article translates recent mechanistic findings into practical DNA damage response assay and cancer research decisions.
-
Digestive Transformations in Withania somnifera Extracts
2026-09-10
This study combines simulated gastrointestinal digestion with LC–MS/MS, untargeted metabolomics, and molecular networking to determine how Withania somnifera extract constituents change before absorption. Its comparison of leaf, root, and purified compounds shows that digestive stability is compound- and matrix-dependent, providing a stronger framework for interpreting botanical bioavailability and designing related exposure-controlled assays.
-
L-Phenylephrine: α1A Assay Workflows
2026-09-09
Build reproducible cardiovascular, neural, and airway research assays with L-Phenylephrine, an adrenergic α1A receptor agonist suited to receptor-proximal and stress-response experiments. This guide connects practical cell workflows with sex-aware baroreflex findings while separating validated observations from assay-development recommendations.
-
CDK4/6–BET Synergy in Pancreatic Cancer
2026-09-09
Gu et al. show that palbociclib can inhibit pancreatic tumor-cell proliferation while unexpectedly intensifying migration, invasion, and epithelial-to-mesenchymal transition through GSK3β-mediated Wnt/β-catenin activation. Combining CDK4/6 inhibition with the BET inhibitor JQ1 restored antitumor activity and suppressed EMT in cell and orthotopic mouse models, providing a mechanistic rationale for combination treatment rather than CDK4/6 blockade alone.
-
Cy3 RNA labeling kit: practical guide
2026-09-08
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports T7-driven in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based workflows. It is intended for research applications such as in situ hybridization and Northern blotting, not for diagnostic, medical, therapeutic, or clinical use.
-
Pleuromutilin Binding at the Ribosomal PTC
2026-09-08
Long et al. combined chemical footprinting with an Escherichia coli L3 mutant model to clarify how tiamulin and related pleuromutilins engage the ribosomal peptidyl transferase center. The study separates conserved interactions made by the mutilin core from adaptable side-chain contacts, providing a mechanistic basis for designing derivatives that retain activity against altered ribosomal binding surfaces.
-
Rottlerin PKC Inhibitor: Assay Workflows
2026-09-07
Rottlerin provides a practical PKC inhibitor framework for connecting PKCδ signaling with cell proliferation inhibition, apoptosis induction, endothelial permeability, and pathogen entry. This guide translates potency data and the S2-cell infection study into controlled workflows, assay checkpoints, and troubleshooting decisions.
-
PPM-18 Workflows for iNOS and NF-κB Studies
2026-09-07
PPM-18 provides a practical way to connect NF-κB activation with downstream iNOS expression, nitrite release, and inflammatory cytokines in macrophage and sepsis research. This workflow emphasizes solvent control, orthogonal readouts, and careful separation of transcriptional inhibition from direct NOS enzyme inhibition.
-
Candida krusei Apoptosis in Bovine Mammary Cells
2026-09-05
Miao et al. show that the yeast and hypha phases of Candida krusei both trigger apoptosis in bovine mammary epithelial cells, but engage different dominant signaling routes. The study combines morphology, flow cytometry, mitochondrial membrane-potential analysis, TUNEL staining, and immunoblotting to distinguish a mitochondrial mechanism for yeast-phase exposure from a death ligand/receptor mechanism for hypha-phase exposure.
-
Coelenterazine: From Light to Causal Insight
2026-09-04
Coelenterazine is a luminescent enzyme substrate that can connect reporter activity with reactive oxygen species chemistry. This guide presents a causal assay framework inspired by brain–kidney research, helping investigators distinguish biological regulation from substrate, matrix, and detection effects.
-
Polybrene Workflows for Mutant p53 Cell Models
2026-09-04
Polybrene improves lentiviral, retroviral, and selected lipid-mediated DNA delivery workflows, helping researchers build more consistent mutant p53 cell models. This guide connects charge-based viral attachment facilitation with practical assay design for evaluating TRAP-1-driven p53Y220C reactivation while emphasizing controls, cytotoxicity testing, and reproducible optimization.
-
DAPT (GSI-IX): From Notch Biology to Translation
2026-09-03
DAPT (GSI-IX) is more than a γ-secretase inhibitor: it is a mechanistic probe for connecting APP processing, Notch signaling, disease biology, and emerging human sensory-neuron models. This thought-leadership guide outlines how translational researchers can use DAPT rigorously while avoiding overinterpretation.
-
From Cartilage Biology to Smarter Cy5.5 Imaging
2026-09-03
A translational framework for using Cy5.5 NHS ester (non-sulfonated) to track biomolecule and nanoparticle behavior in bioadhesive hydrogel systems inspired by a new aged osteoarthritis study.
-
Tolazoline: From Receptor Blockade to Translation
2026-09-02
Tolazoline is more than a conventional α2-adrenergic receptor antagonist: its ability to interrogate presynaptic airway control and ATP-sensitive potassium channel activity makes it a useful translational probe. This article connects equine airway physiology with islet biology, experimental design, and evidence-based positioning for pharmacological research.
-
Epinephrine Bitartrate: Research Workflows
2026-09-01
Epinephrine Bitartrate enables controlled activation of α- and β-adrenergic receptors across cell, ex vivo, and translational studies. This workflow guide connects concentration design with pharmacokinetic timing, intranasal-versus-intramuscular comparisons, and practical troubleshooting.